|
🐜
|
Pharmacological Rescue of Mitochondrial Deficits in iPSC-Derived Neural Cells from Patients with Familial Parkinson’s Disease
40 auth.
O. Cooper,
Hyemyung Seo,
S. Andrabi,
C. Guardia-Laguarta,
J. Graziotto,
M. Sundberg,
J. McLean,
Luis Carrillo-Reid,
Zhong Xie,
Teresia M. Osborn,
G. Hargus,
M. Deleidi,
T. Lawson,
Helle Bogetofte,
E. Pérez-Torres,
...
L. Clark,
C. Moskowitz,
Joseph R. Mazzulli,
Li Chen,
L. Volpicelli-Daley,
Norma Romero,
Houbo Jiang,
R. Uitti,
Zhigao Huang,
G. Opala,
Leslie Scarffe,
V. Dawson,
C. Klein,
Jian Feng,
O. Ross,
J. Trojanowski,
V. Lee,
K. Marder,
D. Surmeier,
Z. Wszolek,
S. Przedborski,
D. Krainc,
T. Dawson,
O. Isacson,
O. Isacson
|
8 |
2012 |
8
🐜
|
|
🐜
|
Translation initiator EIF4G1 mutations in familial Parkinson disease.
50 auth.
M. Chartier-Harlin,
J. Dachsel,
C. Vilariño-Güell,
S. Lincoln,
F. Leprêtre,
M. Hulihan,
J. Kachergus,
A. Milnerwood,
L. Tapia,
M. Song,
É. Le Rhun,
E. Mutez,
L. Larvor,
A. Duflot,
C. Vanbesien-Mailliot,
...
A. Kreisler,
O. Ross,
K. Nishioka,
A. Soto-Ortolaza,
S. A. Cobb,
H. Melrose,
B. Behrouz,
B. Keeling,
Justin A. Bacon,
E. Hentati,
L. Williams,
Akiko Yanagiya,
N. Sonenberg,
P. Lockhart,
A. Zubair,
R. Uitti,
J. Aasly,
A. Krygowska-Wajs,
G. Opala,
Z. Wszolek,
R. Frigerio,
D. Maraganore,
D. Gosal,
T. Lynch,
Michael K. Hutchinson,
A. Bentivoglio,
E. Valente,
W. Nichols,
N. Pankratz,
T. Foroud,
R. Gibson,
F. Hentati,
D. Dickson,
A. Destée,
M. Farrer
|
8 |
2011 |
8
🐜
|
|
🐜
|
neurodegeneration : evidence for association of the p . R 47 H variant with frontotemporal dementia and Parkinson ¿ s disease Permalink
33 auth.
Sruti Rayaprolu,
Bianca Mullen,
M. Baker,
T. Lynch,
E. Finger,
W. Seeley,
K. Hatanpaa,
C. lomen-Hoerth,
A. Kertesz,
E. Bigio,
C. Lippa,
K. Josephs,
D. Knopman,
C. White,
R. Caselli,
...
I. Mackenzie,
B. Miller,
M. Boczarska-Jedynak,
G. Opala,
A. Krygowska-Wajs,
M. Barcikowska,
S. Younkin,
R. Petersen,
N. Ertekin-Taner,
R. Uitti,
J. Meschia,
K. Boylan,
B. Boeve,
N. Graff-Radford,
Z. Wszolek,
D. Dickson,
R. Rademakers,
O. Ross
|
8 |
2013 |
8
🐜
|
|
🐜
|
Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case–control study
69 auth.
O. Ross,
A. Soto-Ortolaza,
M. Heckman,
J. Aasly,
Nadine Abahuni,
G. Annesi,
Justin A. Bacon,
S. Bardien,
M. Bozi,
A. Brice,
L. Brighina,
C. Broeckhoven,
J. Carr,
M. Chartier-Harlin,
M. Chartier-Harlin,
...
E. Dardiotis,
E. Dardiotis,
D. Dickson,
N. Diehl,
A. Elbaz,
A. Elbaz,
C. Ferrarese,
A. Ferraris,
B. Fiske,
J. Gibson,
Rachel Gibson,
G. Hadjigeorgiou,
G. Hadjigeorgiou,
N. Hattori,
J. Ioannidis,
J. Ioannidis,
B. Jasińska‐Myga,
B. Jeon,
Y. Kim,
C. Klein,
R. Krüger,
Elli Kyratzi,
S. Lesage,
S. Lesage,
S. Lesage,
Chin-Hsien Lin,
T. Lynch,
D. Maraganore,
G. Mellick,
E. Mutez,
E. Mutez,
C. Nilsson,
G. Opala,
S. Park,
A. Puschmann,
A. Quattrone,
M. Sharma,
P. Silburn,
Y. Sohn,
L. Stefanis,
V. Tadić,
J. Theuns,
H. Tomiyama,
R. Uitti,
E. Valente,
S. Loo,
D. Vassilatis,
C. Vilariño-Güell,
L. White,
K. Wirdefeldt,
Z. Wszolek,
R. Wu,
M. Farrer,
M. Farrer
|
8 |
2011 |
8
🐜
|
|
🐜
|
Large-scale replication and heterogeneity in Parkinson disease genetic loci
54 auth.
M. Sharma,
J. Ioannidis,
J. Aasly,
G. Annesi,
A. Brice,
C. van Broeckhoven,
L. Bertram,
M. Bozi,
D. Crosiers,
C. Clarke,
M. Facheris,
M. Farrer,
G. Garraux,
S. Gispert,
G. Auburger,
...
C. Vilariño-Güell,
G. Hadjigeorgiou,
Andrew A. Hicks,
N. Hattori,
B. Jeon,
S. Lesage,
C. Lill,
Juei-Jueng Lin,
T. Lynch,
P. Lichtner,
A. Lang,
V. Mok,
B. Jasińska‐Myga,
G. Mellick,
K. Morrison,
G. Opala,
P. Pramstaller,
I. Pichler,
S. Park,
A. Quattrone,
E. Rogaeva,
O. Ross,
L. Stefanis,
Joanne Stockton,
W. Satake,
P. Silburn,
J. Theuns,
E. Tan,
T. Toda,
H. Tomiyama,
R. Uitti,
K. Wirdefeldt,
Z. Wszolek,
G. Xiromerisiou,
K. Yueh,
Yi Zhao,
T. Gasser,
D. Maraganore,
R. Krüger
|
7 |
2012 |
7
🐜
|
|
🐜
|
Creation of an Open-Access, Mutation-Defined Fibroblast Resource for Neurological Disease Research
46 auth.
S. Wray,
Matthew Self,
P. Lewis,
J. Taanman,
N. Ryan,
Colin J. Mahoney,
Yuying Liang,
Michael J. Devine,
U. Sheerin,
H. Houlden,
H. Morris,
D. Healy,
J. Martí‐Massó,
Elisavet Preza,
S. Barker,
...
Margaret Sutherland,
R. Corriveau,
Michael R. D’ANDREA,
A. Schapira,
R. Uitti,
M. Guttman,
G. Opala,
B. Jasińska‐Myga,
A. Puschmann,
C. Nilsson,
A. Espay,
J. Sławek,
L. Gutmann,
B. Boeve,
K. Boylan,
A. Stoessl,
O. Ross,
N. Maragakis,
J. V. van Gerpen,
M. Gerstenhaber,
K. Gwinn,
T. Dawson,
O. Isacson,
K. Marder,
L. Clark,
S. Przedborski,
S. Finkbeiner,
J. Rothstein,
Z. Wszolek,
M. Rossor,
J. Hardy
|
6 |
2012 |
6
🐜
|
|
🐜
|
Heterozygous PINK1 p.G411S increases risk of Parkinson’s disease via a dominant-negative mechanism
33 auth.
A. Puschmann,
F. Fiesel,
T. Caulfield,
R. Hudec,
M. Ando,
Dominika Truban,
Xu Hou,
K. Ogaki,
M. Heckman,
E. James,
M. Swanberg,
Itzia Jimenez-Ferrer,
O. Hansson,
G. Opala,
J. Siuda,
...
M. Boczarska-Jedynak,
A. Friedman,
D. Koziorowski,
M. Rudzińska-Bar,
J. Aasly,
T. Lynch,
G. Mellick,
Megha Mohan,
P. Silburn,
Y. Sanotsky,
C. Vilariño-Güell,
M. Farrer,
Li Chen,
V. Dawson,
T. Dawson,
Z. Wszolek,
O. Ross,
W. Springer
|
6 |
2016 |
6
🐜
|
|
🐜
|
A multi-centre clinico-genetic analysis of the VPS35 gene in Parkinson disease indicates reduced penetrance for disease-associated variants
63 auth.
M. Sharma,
J. Ioannidis,
J. Aasly,
G. Annesi,
A. Brice,
L. Bertram,
M. Bozi,
M. Barcikowska,
D. Crosiers,
C. Clarke,
M. Facheris,
M. Farrer,
G. Garraux,
S. Gispert,
G. Auburger,
...
C. Vilariño-Güell,
G. Hadjigeorgiou,
Andrew A. Hicks,
N. Hattori,
B. Jeon,
Z. Jamrozik,
A. Krygowska-Wajs,
S. Lesage,
C. Lill,
Juei-Jueng Lin,
T. Lynch,
P. Lichtner,
A. Lang,
C. Libioulle,
M. Murata,
V. Mok,
B. Jasińska‐Myga,
G. Mellick,
K. Morrison,
Thomas Meitnger,
A. Zimprich,
G. Opala,
P. Pramstaller,
I. Pichler,
S. Park,
A. Quattrone,
E. Rogaeva,
O. Ross,
L. Stefanis,
Joanne Stockton,
W. Satake,
P. Silburn,
T. Strom,
J. Theuns,
E. Tan,
T. Toda,
H. Tomiyama,
R. Uitti,
C. van Broeckhoven,
K. Wirdefeldt,
Z. Wszolek,
G. Xiromerisiou,
H. Yomono,
K. Yueh,
Yi Zhao,
T. Gasser,
D. Maraganore,
R. Krüger
|
6 |
2012 |
6
🐜
|
|
🐢
|
Factors affecting the health-related quality of life of patients with cervical dystonia and the impact of botulinum toxin type A injections.
11 auth.
J. Sławek,
A. Friedman,
A. Potulska,
P. Krystkowiak,
C. Gervais,
M. Banach,
...
S. Ochudło,
S. Budrewicz,
Daniel Ręcławowicz,
M. Rynkowski,
G. Opala
|
6 |
2007 |
6
🐢
|
|
🐬
|
The association of functional catechol-O-methyltransferase haplotypes with risk of Parkinson's disease, levodopa treatment response, and complications
M. Białecka,
M. Kurzawski,
G. Kłodowska-Duda,
G. Opala,
E. Tan,
M. Droździk
|
6 |
2008 |
6
🐬
|
|
🐜
|
Independent and joint effects of the MAPT and SNCA genes in Parkinson disease
41 auth.
A. Elbaz,
O. Ross,
J. Ioannidis,
A. Soto-Ortolaza,
F. Moisan,
J. Aasly,
G. Annesi,
M. Bozi,
L. Brighina,
M. Chartier-Harlin,
A. Destée,
C. Ferrarese,
A. Ferraris,
J. Gibson,
S. Gispert,
...
G. Hadjigeorgiou,
B. Jasińska‐Myga,
C. Klein,
R. Krüger,
J. Lambert,
K. Lohmann,
S. van de Loo,
M. Loriot,
T. Lynch,
G. Mellick,
E. Mutez,
C. Nilsson,
G. Opala,
A. Puschmann,
A. Quattrone,
M. Sharma,
P. Silburn,
L. Stefanis,
R. Uitti,
E. Valente,
C. Vilariño-Güell,
K. Wirdefeldt,
Z. Wszolek,
G. Xiromerisiou,
D. Maraganore,
M. Farrer
|
6 |
2011 |
6
🐜
|
